©2019 Transparency Market Research, All Rights Reserved

Antibacterial Drugs Market

Drug Class - B - lactams, Quinolones, Macrolides,

Tetracycline, Aminoglycoside, Sulfonamide, and
Phenicols; Routes of Administration - Enteral and
Parenteral; Distribution Channel - Hospital
Pharmacies, Drug Stores and Retail Pharmacies, and
Online Sales
Forecast 2017 - 2025

©2019 Transparency Market Research, All Rights Reserved

 ©2019 Transparency Market Research, All Rights Reserved

Table of Content
Sr. No. Content
Chapter1 Preface

Chapter 2 Research Methodology

Chapter 3 Executive Summary

Chapter 4 Market Overview

Chapter 5 Global Antibacterial Drugs Market Analysis, by Drug Class, 2015 – 2025

Chapter 6 Global Antibacterial Drugs Market Analysis, by Routes of Administration

Chapter 7 Global Antibacterial Drugs Market Analysis, by Channels of Distribution

Chapter 8 Global Antibacterial Drugs Market Analysis, by Region

Chapter 9 North America Antibacterial Drugs Market Analysis

Chapter 10 Europe Antibacterial Drugs Market Analysis

Chapter 11 Asia Pacific Antibacterial Drugs Market Analysis

Chapter 12 Latin America Antibacterial Drugs Market Analysis

Chapter 13 Middle East & Africa Antibacterial Drugs Market Analysis

Chapter 14 Competition Landscape

 ©2019 Transparency Market Research, All Rights Reserved

Antibacterial Drugs Market: Snapshot

• Antibacterial drugs are the chemical substances which are derived from bacterium to cure
bacterial infections. The global antibacterial drugs market is driven by the rapidly
growing antibacterial resistance and demand for new broad spectrum agents.
• Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the
compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments,
considering 2016 as the base year
• Product innovations, improving product portfolio, and geographical expansion will also
be seen as important business strategies by these vendors in the market.
• Leading players in the global antibacterial drugs market include Novartis AG, Allergan,
Plc., Bristol Myers Squibb Company AstraZeneca, Johnson and Johnson, Merck & Co.,
Inc.,

©2019 Transparency Market Research, All Rights Reserved

 ©2019 Transparency Market Research, All Rights Reserved

©2019 Transparency Market Research, All Rights Reserved

 ©2019 Transparency Market Research, All Rights Reserved

Reports Highlights
• The global antibacterial drugs market registered at US$45,325.0 mn in 2016 and is
anticipated to reach a value of US$51,447.6 mn by the end of the 2025. The market is
expected to witness a steady CAGR of 1.5% over the forecast period from 2017 to 2025.

• Growing initiatives by numerous governments and key players for the commercialization
of therapies are expected to bolster the growth of the market. These initiatives have
conducted advancements in enteral routes of administration and available across
numerous developing and developed counties are expected to the uptake of antibacterial
drugs.

• Technological advancements through innovative formulations of drug are expected to

boost adoption of drugs and create potential growth opportunities for the antibacterial
drugs market.

• Rise High with Rapid Development of Biopharmaceutical Sector.

©2019 Transparency Market Research, All
Request Sample
Rights Reserved
 ©2019 Transparency Market Research, All Rights Reserved

To know more about us, please visit our website:

www.transparencymarketresearch.com
For sales queries or new topics email us on:
sales@transparencymarketresearch.com
For other queries contact:
90 State Street, Albany
NY – 12207, United States
Tel: +1-518-618-1030

T H A N K
Y O U